Impact of Alirocumab on Cardiovascular Events in Participants With Atherosclerotic Cardiovascular Disease But Without Prior Ischemic Events

NCT07734753 · clinicaltrials.gov ↗

COMPLETED

Status

4006

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events

Interventions

DRUG: Alirocumab
DRUG: Comparator: No PCSK9i Therapy (monoclonal antibodies or small interfering RNA agents)

Sponsor

Sanofi